Related Experiment Videos
Efficacy of bronchodilators in the treatment of bronchiolitis
Insights
Bronchodilators like Salbutamol and Ipratropium bromide are ineffective for treating bronchiolitis in young children. This study found no significant difference in hospitalisation length or disease severity when using these treatments.
Area of Science:
- Pediatric respiratory medicine
- Clinical pharmacology
Background:
- Bronchiolitis is a frequent respiratory illness in infants and young children.
- The effectiveness of bronchodilator therapy for bronchiolitis remains a subject of debate.
Purpose of the Study:
- To investigate the efficacy of bronchodilators in managing bronchiolitis.
- To compare Salbutamol and Ipratropium bromide against a saline control and a no-nebulization control group.
Main Methods:
- A randomized controlled trial involving 120 children under two years old diagnosed with bronchiolitis.
- Participants were assigned to receive nebulized Salbutamol, Ipratropium bromide, normal saline, or humidified oxygen only.
Main Results:
- No significant differences were observed between the groups regarding disease severity scores or length of hospitalization.
- The number of nebulizations required did not differ significantly among the treatment groups.
Conclusions:
- Bronchodilator administration, including Salbutamol and Ipratropium bromide, does not alter the clinical course of bronchiolitis.
- Current evidence suggests bronchodilators are not effective for treating this common childhood respiratory infection.
Unlabelled:
Bronchiolitis is a common respiratory infection affecting young children. Much controversy revolves around the efficacy of bronchodilators in the treatment of bronchiolitis. This study was conducted to address this issue.
Aim:
To determine the efficacy of bronchodilators in the treatment of bronchiolitis.
Method:
All children less than 2 years old with bronchiolitis were randomly assigned to receive nebulisations of Salbutamol, Ipratropium bromide or normal saline. A fourth group given only humidified oxygen without nebulisation were used as a control.
Results:
Data were obtained for 120 patients. Fifty-one (42%) had respiratory syncytial virus (RSV) isolated from their nasopharyngeal aspirates. The demographic characteristics of the 4 groups were similar. There was no significant difference between the groups in terms of severity score, number of nebulisations required in the nebulised groups and the outcome as measured by the length of hospitalisation.
Conclusion:
The use of bronchodilators did not alter the course of the disease and is therefore not effective in the treatment of bronchiolitis.